Diabetes Information

Benfotiamine - A New Tool In Preventing Diabetic Complications?


Benfotiamine made headlines globally in 2003 when researchers released information about a study that was conducted at The Einstein College of Medicine in New York. The bottom line of this study was that a substance of the allithiamine group of the naturally occurring thiamine-derived compounds had positive effects on neuropathy, retinopathy and nephropathy and heart/circulatory problems in diabetics.

Benfotiamine research has suggested that there are beneficial effects for diabetics and non-diabetics also. These benefits include sciatica, vascular health, general nerve health, lower blood pressure, grant cellular protection, anti-aging, fibromyalgia, prevention of lactic acidosis, and treatment for Alzheimer's disease. Any condition that is the result of a thiamine deficiency will also respond quite well to benfotiamine. Of course, any bodily function that is improved by a therapeutic level of thiamine will certainly be enhanced by benfotiamine, since benfotiamine is perhaps the most effective form of thiamine.

Benfotiamine, a derivative of thiamine (vitamin B1), was an invention of Japanese scientists and there is a U.S. patent on benfotiamine that was entered by the Japanese back in 1962. Japanese benfotiamine is considered the purest source of bulk benfotiamine and is favored by manufacturers globally who insist on the highest quality in their benfotiamine product.

The safety of benfotiamine use has been proven over 12 years of use in Europe for the treatment and prevention of diabetic complications among others. The original Japanese patent on benfotiamine gave information that it is even less toxic than common vitamin B1 (thiamine hydrochloride usually). Orally ingested vitamin B1 has a long history of use as an oral supplement without reported adverse effects. Due to its therapeutic action in some frequently observed clinical syndromes, thiamine hydrochloride has been advised and used over a long period of time. There are no reports of adverse effects of oral thiamine, even at dosages of several hundred milligrams a day (SCOGS, 1978; DHEW, 1979; Marks, 1989).

Benfotiamine has a very good safety record. To date, there has been no reports of any known, negative interactions with any medications. To the contrary, some medications actually can cause a thiamine deficiency in some people and benfotiamine could correct this serious situation.

Many researchers, medical experts, doctors, podiatrists and many medical publishers recommend benfotiamine for neuropathy, retinopathy nephropathy, heart/circulatory complications and B1 deficiencies. Any in depth study on the web will produce physicians, naturopaths, neurologists, optometrists, chiropractors, etc. who have very positive feelings about the effectiveness and potential of benfotiamine in terms of the research done to date on this important tool in the arsenal against neuropathy, retinopathy and beneficial for the heart and circulatory system. We have professional healthcare providers from all of these disciplines which shows the confidence the medical community has in the purity and bioavailability of our benfotiamine product.

Dr. David Williams, publisher of "Alternatives Newsletter", wrote an in depth article concerning benfotiamine in his May, 2004 issue. This article is an eye opener in terms of how effective benfotiamine can be for many health conditions. If possible, it would be beneficial for any interested reader to take a look at this article. For more information about this article you may contact the author below.

Dr Paul Chous is another medical professional who sees the merits of benfotiamine:

"I suspect strongly that benfotiamine will mitigate (or, hopefully, prevent) DRT in humans, but the burden of proof has not yet been met. The case for symptomatic relief of neuropathy symptoms is, of course, more tangible." http://www.emuhealthproducts.com/drchous.html

In conclusion, the consensus for benfotiamine is very positive and are worth investigating. If you or anyone you know is a diabetic, the great possibility of developing diabetic complications over time makes benfotiamine a viable tool in the arsenal for protection. If they are already experiencing complications such as neuropathy, retinopathy, and others, they will benefit from possible reduction in the progression along with pain relief in terms of peripheral neuropathy and other neuropathies.

Zach Malott is CEO of Brentwood Health International, a nutritional supplement company involved in distribution and supplying wholesale, retail and end users.

Mr. Malott is available to discuss the research as it applies to benfotiamine in the treatment and prevention of diabetic complications such as neuropathy and retinopathy.

He can be reached at:

Phone: 505.354.0526

Website: http://www.emuhealthproducts.com


MORE RESOURCES:
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news


Reuters

AstraZeneca diabetes drug cuts heart risks in major study
Reuters
But Ludovic Helfgott, AstraZeneca's head of CV and metabolic diseases, believes the overall data suggests Farxiga could win expanded approval as a diabetes drug with proven heart benefits in a wide range of patients. Full results from the Declare study ...
Diabetes Drug Farxiga Cuts Heart Risks in Topline ResultsAJMC.com Managed Markets Network
AstraZeneca's Diabetes Treatment Reduces Cardiovascular RiskZacks.com

all 47 news articles »


Vital Signs: Fall is a good time to take control of diabetes care
The Daily Progress
If you have diabetes, you know that there is no break from having this chronic disease. No matter what is going on in your personal life, your diabetes will need the same good attention during these busy months that you give it throughout the year ...



The Tribune

Genomic study brings us closer to precision medicine for type 2 diabetes
Science Daily
Most patients diagnosed with type 2 diabetes are treated with a "one-size-fits-all" protocol that is not tailored to each person's physiology and may leave many cases inadequately managed. A new study by scientists at the Broad Institute of MIT and ...
Personalised therapies may help better manage diabetesThe Tribune
Each Diabetic Should Have Personalised Therapy, Tailored To Each Person's Physiology: StudyNDTV
Scientists say genomic study could help cure diabetesDeccan Chronicle

all 29 news articles »


International Diabetes Federation: Families Demand Government Action to Halt the Growing Diabetes Epidemic
PR Newswire (press release)
24, 2018 /PRNewswire/ -- The growing diabetes epidemic will be an important topic when the United Nations General Assembly meets to discuss non-communicable diseases on September 27. Ahead of the meeting, new research from the International ...

and more »


The Daily Gazette

High Notes: Fighting AIDS, diabetes and epilepsy; stocking food bank
The Daily Gazette
In Saratoga Springs, more than 500 cyclists representing 81 chapters of JDRF (formerly the Juvenile Diabetes Research Foundation) raised $1.5 million in the fight against diabetes. More than just a fund-raiser, the Ride to Cure Diabetes brings riders ...
Community walks for type 1 diabetes1011now
Haymarket Park hosts 2018 Walk to End Type 1 DiabetesKLKN
Walk fundraiser for diabetes research to find cureKFYR-TV

all 9 news articles »


KWCH

Fifth grader with Type 1 diabetes dies after blood sugar drops during sleepover
KWCH
Sophia Daugherty, a fifth grader with Type 1 diabetes was found unresponsive Sunday morning at her best friends house in New Castle, according to WPIX. Sophia suffered a hypoglycemic attack that resulted in brain swelling. She was rushed to UPMC ...
Girl, 10, dies after sugar crash sends her into diabetic coma during sleepover with palThe Sun
Girl, 10, dies after sudden sugar crash sent her into diabetic coma during sleepoverMirror.co.uk
9-year-old girl with type 1 diabetes dies during sleepover after sugar crash sends her into a comaMeaww
GoFundMe
all 17 news articles »


Fox News

Pennsylvania girl with diabetes dies after blood sugar drops during sleepover, family says
Fox News
A Pennsylvania community is mourning the death of a 10-year-old girl who was discovered unresponsive at a sleepover on Sunday morning. Sophia Daugherty, a fifth-grader in New Castle, was a Type 1 diabetic, and her family said she suffered an extreme ...
10-year-old girl with diabetes dies after blood sugar drops during sleepoverWPLG Local 10
Fifth Grader With Diabetes Dies After Dramatic Blood Sugar Drop During Sleepover At A Friend's HouseTech Times
Fundraiser by Risa Klenovich Barker : Prayers for Sophia - GoFundMeGoFundMe
WPXI Pittsburgh -New Castle News
all 20 news articles »


Patients with undiagnosed hypertension often have no history of CVD, diabetes
Healio
Patients with undiagnosed hypertension typically had no other CVD or diabetes, according to findings recently published in Family Practice. “A primary care challenge is to identify potential factors that are associated with a higher risk of having ...



Chicago Sun-Times

CPS manager advised nurses to cut back on services for diabetic kids
Chicago Sun-Times
And recent instructions given to some CPS nurses encouraging them to cut back on care for some kids with diabetes “due to the significant number of newly diagnosed students who require daily nursing services” adds new worry to families of ...



New Jersey 101.5 FM Radio

350000 people in NJ have diabetes but don't know it, feds says
New Jersey 101.5 FM Radio
On top of the hundreds of thousands who've been diagnosed, more than 350,000 New Jersey residents are living with diabetes and don't even know it, according to a new report from the Centers for Disease Control and Prevention. That's a number greater ...


Google News

home | site map
© 2009